Neprilysin inhibition promotes skeletal growth via the CNP/NPR-B pathway.
Sign Up to like & getrecommendations! Published in 2024 at "Endocrinology"
DOI: 10.1210/endocr/bqae058
Abstract: C-type natriuretic peptide (CNP) plays a crucial role in enhancing endochondral bone growth and holds promise as a therapeutic agent for impaired skeletal growth. To overcome CNP's short half-life, we explored the potential of dampening… read more here.
Keywords: skeletal growth; inhibition; cnp; promotes skeletal ... See more keywords